Navigation Links
Trial Date Set for Victim Hit by Ambulance
Date:3/24/2008

Louis Del Barba Severely Crippled in Crash in Oakley, California, Last Year

SAN MATEO, Calif., March 24 /PRNewswire/ -- April is set for the trial date of Louis Del Barba vs. American Medical Response, Inc., in Superior Court, County of Alameda, for damages when an ambulance driven by the defendant hit a car driven by Mr. Del Barba. According to police reports, the ambulance was traveling about 70 miles an hour in a 35 mile an hour zone during rush hour traffic. Mr. Del Barba had the right of way when he entered the intersection of Rose Avenue and Main Street. The ensuing crash caused catastrophic injuries to Mr. Del Barba, resulting in quadriplegia and brain damage. The plaintiff was wearing a shoulder and lap belt at the time of the crash.

AMR, a national company, which also owns and operates thousands of school buses, has a history of very serious accidents. Allowing poorly-trained drivers to far exceed speed limits in city traffic endangers all drivers, AMR officials admit.

Terry O'Reilly, attorney for Mr. Del Barba, noted that the ambulance was going far in excess of the speed allowed. "American Medical Response guidelines state that its ambulances can go 10 to 15 miles an hour over the speed limit but Vehicle Code regulations clearly state that an ambulance has the duty of due care to ensure it does not cause an accident on the way to a response. This driver launched himself into a blind intersection without the slightest care for anyone who might be in it."

Witnesses say that the ambulance was driving so fast that no one in the intersection saw or heard any warning until the ambulance slammed into Mr. Del Barba.

The Del Barba family has farmed in Oakley since 1935 and are well-known and popular members of this community in the Sacramento Delta. The community is stunned at Mr. Del Barba's injury.

It will take more than $20,000,000 to care for Mr. Del Barba for his predicted lifespan.

Case number is HG07352258.


'/>"/>
SOURCE Terry O'Reilly
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
2. Only 2 percent of child drug trials have independent safety checks
3. Melt-Away Stent Works Well in Trial
4. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
5. MGH initiates phase I diabetes trial
6. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
7. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
8. Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial
9. Quintiles Data Management Surpasses 300 EDC Trials
10. Sensor necklace aims to increase elderly and clinical trial participant drug compliance
11. Cancer risk slightly higher for women in discontinued hormone treatment trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in ... has a lot to offer to the discussion of dealing with excess skin oil. ... there are many home remedies that can help remove the oily shine while keeping the ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... treatment, with or without a referral. Sleep apnea is often left untreated because patients ... morning headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of ...
(Date:3/27/2017)... London UK (PRWEB) , ... March 27, 2017 ... ... agility and ability to gain site attention and engagement over the household brands ... educational webinar will discuss how partnering with the right outsourcing payments ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 The global market ... with the top three companies, namely Shimadzu Corporation, Thermo ... significant 49% of the overall market in 2015, observes ... landscape is intensely competitive and has few players, most ... These factors have restricted the entry of new players ...
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... 28, 2017  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), ... cancer and other unmet medical needs, announced today ... Cancer Research annual meeting.  The first poster to ... "Evaluation of ENMD-2076 in Combination with Anti-PD1 in ... to be presented on April 4 is entitled ...
Breaking Medicine Technology: